| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.1998.16.6.2253 |
| P698 | PubMed publication ID | 9626228 |
| P50 | author | Charles M. Balch | Q110920550 |
| P2093 | author name string | J E Lee | |
| J J Lee | |||
| J E Gershenwald | |||
| M I Ross | |||
| P F Mansfield | |||
| C Tseng | |||
| M I Colome | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2253-2260 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma | |
| P478 | volume | 16 |
| Q84645336 | A definitive role for sentinel lymph node mapping with biopsy for cutaneous melanoma of the head and neck |
| Q38264727 | A review of sentinel lymph node biopsy for thin melanoma |
| Q35133268 | A selective approach to regional lymphatics in melanoma. |
| Q46695688 | Aberrant lymphatic drainage and risk for melanoma recurrence after negative sentinel node biopsy in middle-aged and older men. |
| Q42937654 | Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate |
| Q50057804 | Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients |
| Q38446183 | Antimony concentrations in nodal tissue can confirm sentinel node identity. |
| Q82255436 | Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma |
| Q34120201 | Biologic and clinical significance of lymphadenectomy |
| Q36165408 | Clinical and biological aspects of sentinel node biopsy in malignant melanoma--an update |
| Q24793452 | Clinical aspects of sentinel node biopsy |
| Q78384441 | Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy |
| Q58748654 | Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma |
| Q46001380 | Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up. |
| Q26747723 | Clinical utilities and biological characteristics of melanoma sentinel lymph nodes |
| Q89726549 | Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma |
| Q64326294 | Complete lymphadenectomy following positive sentinel lymph node biopsy in cutaneous melanoma: a critical review |
| Q78384431 | Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes |
| Q79782675 | Correlation between preoperative lymphoscintigraphy and metastatic nodal disease sites in 362 patients with cutaneous melanomas of the head and neck |
| Q50518940 | Credentialing for breast lymphatic mapping: how many cases are enough? |
| Q33705837 | Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it standard of care? |
| Q34597707 | Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases |
| Q90481838 | Detection of Lymph Node Metastases by Ultra-pH-Sensitive Polymeric Nanoparticles |
| Q40901882 | Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study |
| Q88946303 | Detection of melanoma metastases with the sentinel node biopsy: the legacy of Donald L. Morton, MD (1934-2014) |
| Q35735187 | Development of sentinel lymph node biopsy for melanoma |
| Q34678217 | Early stage (I, II, III) melanoma |
| Q37689491 | Epidemiology and treatment of melanoma in elderly patients |
| Q36504956 | Experimental frontiers for clinical applications: novel approaches to understanding mechanisms of lymph node metastases in melanoma |
| Q91920720 | External validation of a prognostic model to predict survival of patients with sentinel node-negative melanoma |
| Q90620618 | Factors Affecting Growth Kinetics and Spontaneous Metastasis in the B16F10 Syngeneic Murine Melanoma Model |
| Q34120252 | Future perspectives on selective sentinel lymphadenectomy |
| Q47621120 | Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy |
| Q34629376 | Hazard-rate analysis and patterns of recurrence in early stage melanoma: moving towards a rationally designed surveillance strategy |
| Q35587301 | Histopathological patterns of melanoma metastases in sentinel lymph nodes |
| Q64986101 | Impact of sentinel lymph node biopsy in newly diagnosed invasive breast cancer patients with suspicious node: a comparative accuracy survey of fine-needle aspiration biopsy versus core-needle biopsy. |
| Q57741285 | Impact of sentinel lymphadenectomy on survival in a murine model of melanoma |
| Q74479750 | Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma |
| Q33611835 | Importance of tumor load in the sentinel node in melanoma: clinical dilemmas |
| Q24802026 | Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma with 'MCW Melanoma Cocktail' – A mixture of monoclonal antibodies to MART-1, melan-A, and tyrosinase |
| Q42560491 | Increasing Age Is Associated with Worse Prognostic Factors and Increased Distant Recurrences despite Fewer Sentinel Lymph Node Positives in Melanoma |
| Q34677773 | Intermediate- and high-risk melanoma |
| Q37375980 | Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result |
| Q34659721 | Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis |
| Q50508492 | Lympho-gammagraphy and study of sentinel node in cutaneous melanoma |
| Q30310825 | Lymphoscintigraphy and Sentinel Node Biopsy Accurately Stage Melanoma in Patients Presenting After Wide Local Excision |
| Q37878331 | Malignant melanoma of the head and neck: a brief review of pathophysiology, current staging, and management |
| Q85074420 | Management of the Difficult Sentinel Lymph Node in Patients With Primary Cutaneous Melanoma |
| Q77995641 | Management of the axilla in early stage breast cancer: will sentinel node biopsy end the debate? |
| Q35735559 | Melanoma of the head and neck: current concepts in staging, diagnosis, and management |
| Q47803820 | Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual |
| Q33932031 | Melanoma. A multidisciplinary approach for the general surgeon |
| Q37463192 | Meta-analysis of sentinel lymph node positivity in thin melanoma ( |
| Q35785838 | Nanoparticle migration and delivery of Paclitaxel to regional lymph nodes in a large animal model |
| Q34267678 | New lessons from the sentinel node. |
| Q37528762 | Nodular Histologic Subtype and Ulceration are Tumor Factors Associated with High Risk of Recurrence in Sentinel Node-Negative Melanoma Patients. |
| Q34480874 | Optical clearing of archive-compatible paraffin embedded tissue for multiphoton microscopy |
| Q34120211 | Pathologic analysis of the sentinel lymph node |
| Q33712041 | Pathologic examination of the sentinel lymph node in melanoma. |
| Q44675361 | Patterns of early recurrence after sentinel lymph node biopsy for melanoma |
| Q54788585 | Patterns of recurrence in patients with melanoma and histologically negative but RT-PCR-positive sentinel lymph nodes. |
| Q37173922 | Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma |
| Q35116203 | Primary cutaneous melanoma: surgical management and other treatment options |
| Q34140267 | Prognosis of sentinel node staged patients with primary cutaneous melanoma |
| Q35735148 | Prognostic factors in melanoma outcome and survival |
| Q45180237 | Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness <1.00 mm) on the basis of a long-term follow-up. |
| Q35545019 | Reassessing the role of lymphatic mapping and sentinel lymphadenectomy in the management of cutaneous malignant melanoma |
| Q79086859 | Recommendations for an Effective Follow-Up Strategy in Melanoma Patients Should Be Tailored to the Investigations Performed During Initial Staging |
| Q36260669 | Role of sentinel node biopsy in the management and staging of the N0 neck |
| Q35539177 | Sentinel Lymph Node Biopsy Has No Benefit for Patients with Primary Cutaneous Melanoma Metastatic to a Lymph Node: An Assertion Based on Comprehensive, Critical Analysis |
| Q37812813 | Sentinel Lymph Node Biopsy for Melanoma: Critical Assessment at its Twentieth Anniversary |
| Q33944866 | Sentinel lymph node biopsies in cancers of the skin, colon, head and neck, and breast |
| Q34507667 | Sentinel lymph node biopsy in melanoma: our 8-year clinical experience in a single French institute (2002-2009) |
| Q34139808 | Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence |
| Q35805488 | Sentinel lymph node biopsy progress in surgical treatment of cancer |
| Q36501470 | Sentinel lymph node biopsy: is it possible to reduce false negative rates by excluding patients with nodular melanoma? |
| Q53653774 | Sentinel lymph node excision (SLNE) and positron emission tomography in the staging of stage I-II melanoma patients |
| Q73379029 | Sentinel lymph node mapping and biopsy: a potentially valuable tool in the management of childhood extremity rhabdomyosarcoma |
| Q54664158 | Sentinel lymph node: detection of micrometastases of melanoma in a molecular study. |
| Q81787038 | Sentinel node biopsy in patients with cutaneous melanoma of the head and neck: recurrence and survival study |
| Q44473100 | Sentinel node identification and the ability to detect metastatic tumor to inguinal lymph nodes in squamous cell cancer of the vulva |
| Q36616239 | Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis |
| Q73251784 | Should irradiation replace dissection for patients with breast cancer with clinically negative axillary lymph nodes? |
| Q36304025 | Should sentinel lymph-node biopsy be used routinely for staging melanoma and breast cancers? |
| Q34625447 | Staging and prognosis of cutaneous melanoma |
| Q33873094 | State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center |
| Q36393331 | Surgery and sentinel lymph node biopsy |
| Q38646103 | Surgical Management of Melanoma |
| Q89208524 | Systematic review of sentinel lymph node biopsy in Merkel cell carcinoma of the head and neck |
| Q87671495 | The Value of Sentinel Lymph Node Biopsy in Oral Cavity Cancers |
| Q42787369 | The argument against sentinel node biopsy for malignant melanoma |
| Q50494192 | The impact of immunohistochemistry on sentinel node biopsy for primary cutaneous malignant melanoma. |
| Q50517438 | The role of sentinel lymph node biopsy in breast cancer. |
| Q34584396 | The role of sentinel lymph node biopsy in the management of melanoma |
| Q35588719 | The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status |
| Q33811544 | Therapeutic advances in melanoma |
| Q36296269 | Treatment strategy for cutaneous malignant melanoma |
| Q59235516 | Tumour mutation status and melanoma recurrence following a negative sentinel lymph node biopsy |
| Q36577550 | Tumour-induced immune modulation of sentinel lymph nodes |
| Q80951700 | Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis |
| Q37314758 | Utility of frozen-section analysis of sentinel lymph node biopsy specimens for melanoma in surgical decision making |
| Q33752235 | Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group |
| Q77376752 | Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma |
| Q47578223 | Vulvar melanoma: is there a role for sentinel lymph node biopsy? |
| Q73466382 | [Selection of patients for sentinel lymphnode biopsy in melanoma] |
| Q80385908 | [Sentinel lymph node in melanoma] |
| Q81331234 | [The role of sentinel lymph node biopsy in the diagnosis and prognosis of malignant melanoma] |
| Q73144598 | [The sentinel lymph node in resectable cancer of the breast] |
Search more.